ROSEVILLE, Minn., Sept. 22, 2022 /PRNewswire/ — Calyxt, Inc. (NASDAQ: CLXT) (“Calyxt”), a plant-based synthetic biology company, today announced that its Board of Directors is evaluating potential strategic alternatives to maximize shareholder value. As part of the process, the Board is…
Related Posts
Vermilion Energy Inc. Announces Second Quarter 2022 Release Date and Conference Call and Webcast Details
CALGARY, AB, July 28, 2022 /PRNewswire/ – Vermilion Energy Inc. (“Vermilion”, “We”, “Our”, “Us” or the “Company”) (TSX: VET) (NYSE:…
envelios Intelligent Grid Platform digitalisiert Netzanschlussprüfung im digitalen Vorreiterland Estland
KÖLN, Deutschland, 10. August 2022 /PRNewswire/ — Enefit, Elektrilevi und envelio GmbH arbeiten im Rahmen eines vollständigen Rollout-Projektes der Intelligent…
Scrubber System Market to Reach $13.86 Billion, Globally, by 2031 at 4.8% CAGR: Allied Market Research
Rise in demand for products, such as food & beverage, oil & gas, and pharmaceutical and increase in manufacturing facilities…